You just read:

Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP)

News provided by

Abbott

Aug 16, 2011, 03:19 ET